Pacific Northwest Research Institute

Pacific Northwest Research Institute, a Seattle-based nonprofit research organization, operates as a federal grant recipient conducting biomedical and life-sciences research across the National Institutes of Health, the National Cancer Institute, and the National Science Foundation. The institute functions as a prime recipient on 39 of 47 recent federal awards (83%) and as a sub-recipient on 8 grant sub-awards routed through university prime recipients including the University of Washington, the University of South Florida, Baylor College of Medicine, and the University of Colorado.

The institute's research portfolio centers on genomic medicine, infectious disease, and cancer biology. Representative prime-recipient work includes a $1,231,446 National Institute of General Medical Sciences project grant (CFDA 93.859, awarded August 2026, running through May 2031) investigating the origin and functional impact of structural variants in rare genetic diseases, with focus on DNA repair mechanisms including break-induced replication and microhomology-mediated break-induced replication in highly similar intrachromosomal repeats. A second NIGMS project grant (awarded August 2024, completing July 2027) extends this work to understand how highly similar intrachromosomal repeats contribute to genomic instability and gene expression perturbation in genetic disorders. The National Institute of Child Health and Human Development awarded a project grant (CFDA not specified, May 2024, completing February 2029) to develop and apply variant interpretation platforms for detecting urea cycle disorders via newborn genome sequencing. Additional NIGMS and National Institute of Allergy and Infectious Diseases grants investigate reverse transcriptase-mediated expansion of innate immunity genes and retrocopies of viral restriction factors. A National Cancer Institute grant (January 2022, completing December 2026) uses bivalve transmissible neoplasia as a model system to identify host factors blocking cancer cell engraftment and progression, with implications for acute myeloid leukemia research. The institute also holds a Division of Environmental Biology grant (September 2022, completing August 2027) quantifying transmission dynamics of bivalve transmissible neoplasia through field surveys and laboratory experiments, including engagement with Coast Salish tribal research partners.

Customer concentration sits predominantly within NIH's extramural grant portfolio. The top five customer entities by award count account for 60% of recent awards, led by NIH's general and institute-specific programs: NIH broadly (8 awards), the National Institute of Diabetes and Digestive and Kidney Diseases (8 awards), the National Institute of General Medical Sciences (6 awards), and the National Human Genome Research Institute (3 awards). The Department of the Navy holds 3 awards, likely reflecting the institute's sea-based research capacity. The institute has also engaged with 18 distinct federal customer agencies across the available record, stretching back to 1982.

In its sub-recipient role, Pacific Northwest Research Institute delivers research services through partnerships with major university medical centers. Named sub-awards include the University of Washington Mendelian Genomics Data Coordinating Center (multiple sub-awards across 2023–2025), the Environmental Determinants of Diabetes in the Young (TEDDY) study routed through the University of South Florida (multiple sub-awards through 2024–2025), the Natural History of Pre-Diabetic Autoimmunity (DAISY) study through the University of Colorado (July 2024), and a Baylor College of Medicine exRNA research initiative (January 2023, $410,152 total with annual amendments). A principal scientist at the institute has directed the Scientific Outreach Committee for the NIH exRNA Portal consortium, coordinating multi-institutional research communication.

Activity has grown modestly — three awards in 2022, one in 2023, seven in 2024, two in 2025, and one in 2026 — with three awards facing ultimate completion within the next twenty-four months. The Service Contract Inventory dataset captures minimal SCI-reportable activity: 0.3 FTEs in FY2025 as a named subcontractor on a single SCI-covered record, indicating that the institute's federal revenue flows primarily through grant mechanisms rather than service-contract vehicles. The institute's award footprint reflects its positioning as a research-performing institution within the NIH extramural portfolio, with specialized capacity in genomic sequencing, variant interpretation, and model-organism research in transmissible disease systems.